ONEMEDNET CORPORATION Increase (Decrease) in Accrued Liabilities
ONEMEDNET CORPORATION (ONMD) reported Increase (Decrease) in Accrued Liabilities of $1.16 million for the 9-month period ending 2023-09-30, per its 10-Q/A filed 2023-12-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2023-12-18
- ONEMEDNET CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2023-09-30 was $796.46K, a 263.42% increase year-over-year.
- ONEMEDNET CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2023-06-30 was $105.63K, a 80.78% decline year-over-year.
- ONEMEDNET CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2023-03-31 was $253.84K, a 34.99% decline year-over-year.
- ONEMEDNET CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2022-12-31 was $394.74K.
- ONEMEDNET CORPORATION increase (decrease) in accrued liabilities for fiscal 2022 was $1.55M.
| Period end | Increase (Decrease) in Accrued Liabilities 2 month | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 5 month | Increase (Decrease) in Accrued Liabilities 5 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 8 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 11 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | $796.46K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2023-12-18 | $902.09K derived: sum of 2 quarters · filed 2023-12-18 | $1.16M 10-Q/A · filed 2023-12-18 | $1.55M derived: sum of 4 quarters · filed 2023-12-18 | |||||
| 2023-06-30 | $105.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $359.47K 10-Q · filed 2023-08-14 | $754.21K derived: sum of 3 quarters · filed 2023-08-14 | $973.37K derived: sum of 4 quarters · filed 2023-12-18 | |||||
| 2023-03-31 | $253.84K 10-Q · filed 2023-05-19 | $648.58K derived: sum of 2 quarters · filed 2023-05-19 | $867.73K derived: sum of 3 quarters · filed 2023-12-18 | $1.42M derived: sum of 4 quarters · filed 2023-12-18 | |||||
| 2022-12-31 | $394.74K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-31 | $613.89K derived: sum of 2 quarters · filed 2023-12-18 | $1.16M derived: sum of 3 quarters · filed 2023-12-18 | $1.55M 10-K · filed 2023-03-31 | |||||
| 2022-09-30 | $219.16K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2023-12-18 | $768.68K derived: sum of 2 quarters · filed 2023-12-18 | $1.16M 10-Q/A · filed 2023-12-18 | ||||||
| 2022-06-30 | $549.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $939.96K 10-Q · filed 2023-08-14 | |||||||
| 2022-03-31 | $390.44K 10-Q · filed 2023-05-19 | ||||||||
| 2021-12-31 | $125.97K 10-K · filed 2023-03-31 | ||||||||
| 2021-09-30 | $16.13K 10-Q · filed 2022-11-18 | ||||||||
| 2021-06-30 | $51.81K 10-Q · filed 2022-08-15 | $50.97K 10-Q · filed 2021-08-16 | |||||||
| 2021-03-31 | $845.00 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |